The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations

Journal of Pediatrics

Volumn 144, Issue 5 SUPPL., 2004, Pages

  Muenzer, Joseph ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGALSIDASE ALFA; AGALSIDASE BETA; ALGLUCERASE; GALSULFASE; IDURONATE 2 SULFATASE; IMIGLUCERASE; LARONIDASE; LEVO IDURONIDASE; N ACETYLGALACTOSAMINE 4 SULFATASE; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; AORTA VALVE REGURGITATION; CARPAL TUNNEL SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CORNEA OPACITY; DISEASE CLASSIFICATION; ENZYMATIC ASSAY; GAUCHER DISEASE; GENETIC HETEROGENEITY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; HYDROCEPHALUS; KYPHOSIS; MAROTEAUX LAMY SYNDROME; MITRAL VALVE REGURGITATION; MORQUIO SYNDROME; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SANFILIPPO SYNDROME; SCHEIE SYNDROME; SLEEP APNEA SYNDROME; SPINAL CORD COMPRESSION; TOXICITY;

EID: 2342589511     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.01.052     Document Type: Conference Paper

References (22)

1. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited disease. New York: McGraw Hill; 2001. p. 3421-52.
2. Hopwood JJ, Morris CP. The mucopolysaccharidoses: diagnosis, molecular genetics and treatment. Mol Biol Med 1990;7:381-404.
3. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54.
4. Clarke LA. Clinical diagnosis of lysosomal storage diseases. In: Applegarth DA, Dimmick JE, Hall JG, eds. Organelle diseases. London: Chapman and Hall; 1997. p. 37-71.
5. Natowicz MR, Short MP, Wang Y, Dickersin GR, Gebhardt MC, Rosenthal DI, et al. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med 1996;335:1029-33.
6. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD(R)): 2003 update. Hum Mutat 2003;21:577-81.
7. Colville GA, Bax MA. Early presentation in the mucopolysaccharide disorders. Child Care Health Dev 1996;22:31-6.
8. Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996;87:4894-902.
9. Guffon N, Souillet G, Maire I, Straczek J, Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998;133:119-25.
10. Hite SH, Peters C, Krivit W. Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H). Pediatr Radiol 2000;30:464-70.
11. Kachur E, Del Maestro R. Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 2000;47:223-228; discussion 8-9.
12. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, et al. Hurler syndrome, II: outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998;91:2601-8.
13. Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringden O, Kapaun P, Ortega JJ, et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation. Lancet 1995;345:1398-402.
14. Vellodi A, Young E, Cooper A, Lidchi V, Winchester B, Wraith JE. Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis 1999;22:638-48.
15. Herskhovitz E, Young E, Rainer J, Hall CM, Lidchi V, Chong K, et al. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up. J Inherit Metab Dis 1999;22:50-62.
16. Wraith JE. Advances in the treatment of lysosomal storage disease. Dev Med Child Neurol 2001;43:639-46.
17. Krivit W. Stem cell bone marrow transplantation in patients with metabolic storage diseases. Adv Pediatr 2002;49:359-78.
18. Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med 2002;113:112-9.
19. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry's disease. N Engl J Med 2001;345:9-16.
20. Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial JAMA 2001;285:2743-9.
21. Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344:182-8.
22. Clarke L, Muenzer J, Kolodny EH, Pastores G, Beck M, Wraith JE. RhIDU enzyme replacement therapy for MPS I: 24 week extension study. Am J Hum Genet 2002;71(Suppl):481.